News Agency
Men's Weekly

Abivax: ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory epithelium model

  • Written by Media Outreach

ABX464 is the only drug candidate with a potential triple action for COVID-19 treatment: antiviral, anti-inflammatory and tissue repair

 

  • ABX464, as assessed by RTqPCR, inhibits in vitro viral replication of SARS-CoV-2 (COVID-19)
  • Simultaneously, Abivax receives ANSM and CPP clearance[1] to test ABX464 as promising COVID-19 therapeutic candidate...

Read more: Abivax: ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory...

The Real Value of All-on-4: Brisbane Dentists Explain the Long-Term Benefits

Tooth loss can be a distressing and life-altering experience. Beyond the immediate impact on chewing, speaking, and appearance, missing teeth can lead to declining self-confidence, social anxiety, and long-term oral health complications. Fortunately, modern dental technology has revolutionised tooth replacement... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion